- Home
- QURE vs UPST Comparison
QURE vs UPST Comparison
Compare QURE & UPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QURE | UPST |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.9B |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | QURE | UPST |
|---|---|---|
| Price | $43.04 | $25.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 16 |
| Target Price | $45.00 | ★ $45.84 |
| AVG Volume (30 Days) | 1.1M | ★ 4.0M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.67 | ★ 131.25 |
| EPS | N/A | ★ 0.10 |
| Revenue | $13,107,000.00 | ★ $1,043,857,000.00 |
| Revenue This Year | $126.12 | $34.45 |
| Revenue Next Year | $200.43 | $32.64 |
| P/E Ratio | ★ N/A | $255.90 |
| Revenue Growth | N/A | ★ 63.99 |
| 52 Week Low | $8.73 | $23.97 |
| 52 Week High | $71.50 | $71.38 |
Technical Indicators
Market Signals| Indicator | QURE | UPST |
|---|---|---|
| Relative Strength Index (RSI) | 46.24 | 38.99 |
| Support Level | $39.50 | $25.32 |
| Resistance Level | $51.09 | $31.23 |
| Average True Range (ATR) | 2.05 | 1.22 |
| MACD | -0.66 | -0.36 |
| Stochastic Oscillator | 21.68 | 15.05 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About UPST Upstart Holdings Inc.
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. The company support development of different lending product offerings, which are grouped into three operating segments - Personal Lending (unsecured personal loans and small dollar loans), Auto Lending (auto refinance, auto retail loans, and auto secured personal loans), and Other (HELOCs and other).